Articles |
the Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Conn.
Correspondence to Dr Jordan S. Pober, Boyer Center for Molecular Medicine, Yale University School of Medicine, 295 Congress Ave, New Haven, CT 06536-0812.
Tumor necrosis factor (TNF) activates transcription of endothelial leukocyte adhesion molecule-1 (CD62E) in endothelial cells (ECs) through the binding to the gene promoter of the p50/p65 heterodimeric form of nuclear factor-
B (NF-
B) and of the N-terminal phosphorylated form of the ATF2/c-Jun transcription factor, which is phosphorylated by Jun N-terminal kinase (JNK). However, the intracellular signaling pathways that activate endothelial NF-
B and JNK in TNF-induced responses are unknown. In this study we have examined the role of a recently described TNF signaling pathway involving sphingomyelin activation to generate ceramide, a potential intracellular mediator. We find that concentrations of TNF that strongly activate NF-
B and JNK within 15 minutes do not produce either a measurable decline in sphingomyelin or a measurable generation of ceramide in cultured human umbilical vein ECs at any time examined. Stimulation of ECs with purified sphingomyelinase (SMase) enzyme causes a rapid 60% to 80% decrease in cellular sphingomyelin content and a large increase in ceramide. However, SMase treatment only minimally activates NF-
B, achieving levels that are insufficient to initiate gene transcription. Extracellular SMase does not have access to intracellular sphingomyelin, but treatment of ECs with membrane-permeant ceramide analogues still completely fails to activate NF-
B and only activates JNK at late times. Neither SMase nor ceramide analogues induce gene transcription or surface expression of endothelial leukocyte adhesion molecules that are readily induced by TNF. Strikingly, low concentrations of membrane-permeant ceramide cause programmed cell death in ECs, a finding not observed at any concentrations of TNF tested. We conclude that ceramide is not an important second messenger for TNF signaling of gene transcription in ECs but may be a second messenger for cell death in response to as-yet-unidentified signals.
Key Words: vascular endothelial cell tumor necrosis factor sphingomyelinase ceramide cell death
This article has been cited by other articles:
![]() |
T. R. Medler, D. N. Petrusca, P. J. Lee, W. C. Hubbard, E. V. Berdyshev, J. Skirball, K. Kamocki, E. Schuchman, R. M. Tuder, and I. Petrache Apoptotic Sphingolipid Signaling by Ceramides in Lung Endothelial Cells Am. J. Respir. Cell Mol. Biol., June 1, 2008; 38(6): 639 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liu, M. S. Kluger, A. D'Alessio, G. Garcia-Cardena, and J. S. Pober Regulation of Arterial-Venous Differences in Tumor Necrosis Factor Responsiveness of Endothelial Cells by Anatomic Context Am. J. Pathol., April 1, 2008; 172(4): 1088 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Enis, B. R. Shepherd, Y. Wang, A. Qasim, C. M. Shanahan, P. L. Weissberg, M. Kashgarian, J. S. Pober, and J. S. Schechner Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells PNAS, January 11, 2005; 102(2): 425 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Madge, J.-H. Li, J. Choi, and J. S. Pober Inhibition of Phosphatidylinositol 3-Kinase Sensitizes Vascular Endothelial Cells to Cytokine-initiated Cathepsin-dependent Apoptosis J. Biol. Chem., May 30, 2003; 278(23): 21295 - 21306. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Levade, N. Auge, R. J. Veldman, O. Cuvillier, A. Negre-Salvayre, and R. Salvayre Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology Circ. Res., November 23, 2001; 89(11): 957 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Spyridopoulos, P. Mayer, K. S. Shook, D. I. Axel, R. Viebahn, and K. R. Karsch Loss of cyclin A and G1-cell cycle arrest are a prerequisite of ceramide-induced toxicity in human arterial endothelial cells Cardiovasc Res, April 1, 2001; 50(1): 97 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Schechner, A. K. Nath, L. Zheng, M. S. Kluger, C. C. W. Hughes, M. R. Sierra-Honigmann, M. I. Lorber, G. Tellides, M. Kashgarian, A. L. M. Bothwell, et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse PNAS, July 5, 2000; (2000) 150242297. [Abstract] [Full Text] |
||||
![]() |
C. Phan, A. W. McMahon, R. C. Nelson, J. F. Elliott, and A. G. Murray Activated Lymphocytes Promote Endothelial Cell Detachment from Matrix: A Role for Modulation of Endothelial Cell {beta}1 Integrin Affinity J. Immunol., October 15, 1999; 163(8): 4557 - 4563. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kinoshita and K. Shimokado Autocrine FGF-2 Is Responsible for the Cell Density-Dependent Susceptibility to Apoptosis of HUVEC : A Role of a Calpain Inhibitor-Sensitive Mechanism Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2323 - 2329. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Madge, M. R. Sierra-Honigmann, and J. S. Pober Apoptosis-inducing Agents Cause Rapid Shedding of Tumor Necrosis Factor Receptor 1 (TNFR1). A NONPHARMACOLOGICAL EXPLANATION FOR INHIBITION OF TNF-MEDIATED ACTIVATION J. Biol. Chem., May 7, 1999; 274(19): 13643 - 13649. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Medvedev, J. C. G. Blanco, N. Qureshi, and S. N. Vogel Limited Role of Ceramide in Lipopolysaccharide-mediated Mitogen-activated Protein Kinase Activation, Transcription Factor Induction, and Cytokine Release J. Biol. Chem., April 2, 1999; 274(14): 9342 - 9350. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Guo, B. Kang, L.-J. Yang, and J. R. Williamson Tumor necrosis factor-alpha and ceramide induce cell death through different mechanisms in rat mesangial cells Am J Physiol Renal Physiol, March 1, 1999; 276(3): F390 - F397. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Xia, J. R. Gamble, K.-A. Rye, L. Wang, C. S. T. Hii, P. Cockerill, Y. Khew-Goodall, A. G. Bert, P. J. Barter, and M. A. Vadas Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway PNAS, November 24, 1998; 95(24): 14196 - 14201. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Katsuyama, M. Shichiri, F. Marumo, and Y. Hirata Role of Nuclear Factor-{kappa}B Activation in Cytokine- and Sphingomyelinase-Stimulated Inducible Nitric Oxide Synthase Gene Expression in Vascular Smooth Muscle Cells Endocrinology, November 1, 1998; 139(11): 4506 - 4512. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Harada-Shiba, M. Kinoshita, H. Kamido, and K. Shimokado Oxidized Low Density Lipoprotein Induces Apoptosis in Cultured Human Umbilical Vein Endothelial Cells by Common and Unique Mechanisms J. Biol. Chem., April 17, 1998; 273(16): 9681 - 9687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Allan-Yorke, M. Record, C. de Preval, C. Davrinche, and J.-L. Davignon Distinct Pathways for Tumor Necrosis Factor Alpha and Ceramides in Human Cytomegalovirus Infection J. Virol., March 1, 1998; 72(3): 2316 - 2322. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cho, L. Mitchell, D. Koopmans, and B. L. Langille Effects of Changes in Blood Flow Rate on Cell Death and Cell Proliferation in Carotid Arteries of Immature Rabbits Circ. Res., September 19, 1997; 81(3): 328 - 337. [Abstract] [Full Text] |
||||
![]() |
J. S. Schechner, A. K. Nath, L. Zheng, M. S. Kluger, C. C. W. Hughes, M. R. Sierra-Honigmann, M. I. Lorber, G. Tellides, M. Kashgarian, A. L. M. Bothwell, et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse PNAS, August 1, 2000; 97(16): 9191 - 9196. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |